Vaccine design: the subunit and adjuvant approach
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Plenum Press
1995
|
| Schriftenreihe: | Pharmaceutical biotechnology
6 |
| Schlagworte: | |
| Beschreibung: | XLIV, 949 S. graph. Darst. |
| ISBN: | 030644867X |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011225047 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 970228s1995 d||| |||| 00||| eng d | ||
| 020 | |a 030644867X |9 0-306-44867-X | ||
| 035 | |a (OCoLC)32430019 | ||
| 035 | |a (DE-599)BVBBV011225047 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-578 | ||
| 050 | 0 | |a QR189 | |
| 082 | 0 | |a 615/.372 |2 20 | |
| 084 | |a VS 9000 |0 (DE-625)147724:253 |2 rvk | ||
| 245 | 1 | 0 | |a Vaccine design |b the subunit and adjuvant approach |c ed. by Michael F. Powell ... |
| 264 | 1 | |a New York [u.a.] |b Plenum Press |c 1995 | |
| 300 | |a XLIV, 949 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Pharmaceutical biotechnology |v 6 | |
| 650 | 7 | |a Adjuvantia |2 gtt | |
| 650 | 7 | |a Vaccins |2 gtt | |
| 650 | 4 | |a Adjuvants, Immunologic | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Immunological adjuvants | |
| 650 | 4 | |a Vaccines | |
| 650 | 0 | 7 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | 1 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 1 | 1 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Powell, Michael F. |e Sonstige |4 oth | |
| 830 | 0 | |a Pharmaceutical biotechnology |v 6 |w (DE-604)BV007730074 |9 6 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007531433 | ||
Datensatz im Suchindex
| _version_ | 1804125723949006848 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV011225047 |
| callnumber-first | Q - Science |
| callnumber-label | QR189 |
| callnumber-raw | QR189 |
| callnumber-search | QR189 |
| callnumber-sort | QR 3189 |
| callnumber-subject | QR - Microbiology |
| classification_rvk | VS 9000 |
| ctrlnum | (OCoLC)32430019 (DE-599)BVBBV011225047 |
| dewey-full | 615/.372 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.372 |
| dewey-search | 615/.372 |
| dewey-sort | 3615 3372 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01636nam a2200493 cb4500</leader><controlfield tag="001">BV011225047</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970228s1995 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">030644867X</subfield><subfield code="9">0-306-44867-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)32430019</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011225047</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR189</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.372</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9000</subfield><subfield code="0">(DE-625)147724:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vaccine design</subfield><subfield code="b">the subunit and adjuvant approach</subfield><subfield code="c">ed. by Michael F. Powell ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Plenum Press</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XLIV, 949 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Pharmaceutical biotechnology</subfield><subfield code="v">6</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Adjuvantia</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccins</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adjuvants, Immunologic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunological adjuvants</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Powell, Michael F.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Pharmaceutical biotechnology</subfield><subfield code="v">6</subfield><subfield code="w">(DE-604)BV007730074</subfield><subfield code="9">6</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007531433</subfield></datafield></record></collection> |
| id | DE-604.BV011225047 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:06:06Z |
| institution | BVB |
| isbn | 030644867X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007531433 |
| oclc_num | 32430019 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-578 |
| physical | XLIV, 949 S. graph. Darst. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Plenum Press |
| record_format | marc |
| series | Pharmaceutical biotechnology |
| series2 | Pharmaceutical biotechnology |
| spelling | Vaccine design the subunit and adjuvant approach ed. by Michael F. Powell ... New York [u.a.] Plenum Press 1995 XLIV, 949 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Pharmaceutical biotechnology 6 Adjuvantia gtt Vaccins gtt Adjuvants, Immunologic Drug Design Immunological adjuvants Vaccines Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf Impfstoff (DE-588)4026655-2 s Arzneimitteldesign (DE-588)4278218-1 s DE-604 Pharmazeutische Technologie (DE-588)4045699-7 s Powell, Michael F. Sonstige oth Pharmaceutical biotechnology 6 (DE-604)BV007730074 6 |
| spellingShingle | Vaccine design the subunit and adjuvant approach Pharmaceutical biotechnology Adjuvantia gtt Vaccins gtt Adjuvants, Immunologic Drug Design Immunological adjuvants Vaccines Pharmazeutische Technologie (DE-588)4045699-7 gnd Impfstoff (DE-588)4026655-2 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
| subject_GND | (DE-588)4045699-7 (DE-588)4026655-2 (DE-588)4278218-1 |
| title | Vaccine design the subunit and adjuvant approach |
| title_auth | Vaccine design the subunit and adjuvant approach |
| title_exact_search | Vaccine design the subunit and adjuvant approach |
| title_full | Vaccine design the subunit and adjuvant approach ed. by Michael F. Powell ... |
| title_fullStr | Vaccine design the subunit and adjuvant approach ed. by Michael F. Powell ... |
| title_full_unstemmed | Vaccine design the subunit and adjuvant approach ed. by Michael F. Powell ... |
| title_short | Vaccine design |
| title_sort | vaccine design the subunit and adjuvant approach |
| title_sub | the subunit and adjuvant approach |
| topic | Adjuvantia gtt Vaccins gtt Adjuvants, Immunologic Drug Design Immunological adjuvants Vaccines Pharmazeutische Technologie (DE-588)4045699-7 gnd Impfstoff (DE-588)4026655-2 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
| topic_facet | Adjuvantia Vaccins Adjuvants, Immunologic Drug Design Immunological adjuvants Vaccines Pharmazeutische Technologie Impfstoff Arzneimitteldesign |
| volume_link | (DE-604)BV007730074 |
| work_keys_str_mv | AT powellmichaelf vaccinedesignthesubunitandadjuvantapproach |